What has been going on in the life sciences world this week? Find out in this week’s edition of Week in Brief.
Using a mouse model, researchers have demonstrated a precision DNA editing strategy that corrects a mutation responsible for a severe form of childhood epilepsy. The treatment reduced seizures and improved survival, highlighting the potential of one-off genomic therapies that address the underlying cause of neurological disease rather than only managing symptoms.
A clinical trial has shown that men with localised prostate cancer can safely receive radiotherapy in just two treatment sessions instead of the standard five. Using MRI-guided technology, the shorter regimen achieved similar side-effect profiles and quality-of-life outcomes.
New research into has reinforced the idea that the timing of exposure to common infections may influence childhood cancer risk. The findings support evidence that delayed immune system stimulation early in life could contribute to the development of acute lymphoblastic leukaemia in genetically susceptible children.
Scientists have uncovered a previously unknown function for a cancer-associated protein, which protects fragile regions of the genome from accumulating damage. The work suggests that tumours carrying SMARCA4 mutations may be especially vulnerable to drugs that target unusual DNA structures.
A large multi-omics study has found that both ancestry and environment shape the biology of ageing, influencing immune activity, metabolism and the gut microbiome. The research also revealed that relocating to different geographic regions can alter molecular ageing patterns, underlining the importance of personalised approaches in precision medicine.
Researchers have shown that genes provide developing neurons with molecular guidance cues, like a ‘GPS’, that help establish the brain’s neural circuitry. Using computational analysis of mouse brain data, the study offers new insight into how complex neural networks are organised during development.
Scientists have developed a low-cost diagnostic tool capable of identifying cancer-driving gene fusions in paediatric leukaemia with high precision. The approach uses long-read RNA sequencing and could simplify current testing workflows while improving the accuracy of childhood cancer diagnosis.
Researchers have identified genetic factors linked to an increased likelihood of limb amputation in some patients with peripheral artery disease, providing new insights into why outcomes can differ substantially between individuals. The findings could help clinicians identify high-risk patients earlier and guide more personalised treatment strategies.
A study has revealed that many adults carry previously undetected genetic conditions that only become apparent later in life. The findings highlight how broader use of genomic screening could improve diagnosis and allow earlier intervention.
Scientists have identified a gene signature that may help predict how patients with triple-negative breast cancer respond to chemotherapy. The work could support more tailored treatment decisions by identifying individuals most likely to benefit from specific therapeutic approaches.
Check out last week’s Week in Brief here.
